Indole-3-carbinol

DB12881InvestigationalSmall molecule

Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).

Formula / weight: C₉H₉NO · 147.1739 g/mol (avg)
Code names: NSC-525801

Resolves to

Compound

UNIIC11E72455FCAS700-06-1ChEMBLCHEMBL155625ChEBI24814PubChem3712

Clinical / RWD

RxNorm2598119

Structure

InChIKeyIVYPNXXAYMYVSP-UHFFFAOYSA-NSMILESOCC1=CNC2=CC=CC=C12

Targets

P25963NFKBIA

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

39Drug interactionsStructured to mechanism, not free text

7Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Indole-3-carbinol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account